0A5J.ILIOB
Dermapharm Holding SE
€49.16
ListedOct 9, 2020
SectorHealthcare
IndustryDrug Manufacturers — Specialty & Generic
CountryGermany
Employees3404
State-| CityGrünwald| AddressLil-Dagover-Ring 7| Phone49 89 6 41 86 0
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription healthcare products, herbal extracts, and other pharmaceutical products. It offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. The company also provides medical devices under the bite away and Herpotherm names. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE operates as a subsidiary of Themis Beteiligungs-AG.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
21.6
?
Div. Rate
€1.05
?
Div. Yield
2.75%
?
Payout Ratio
46.05%
?
Max Consec. Div. Years
5 years
?
Longest Consec. Div.
5 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.48
?
Div. Growth Rate
50.00%
?
Score
76

Dividend History

Historical dividend payments by ex-dividend date.

Jun 27, 2025
€ 0.9000
Jun 28, 2024
€ 0.8800
Jun 15, 2023
€ 1.0500
Jun 1, 2022
€ 2.1700
Jun 24, 2021
€ 0.8800

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!